Jul 28, 2024, 07:55
Luciano J Costa: MRD accelerating myeloma drug development
Rahul Banerjee, Assistant Professor at UW Medicine, shared a post by Luciano J Costa, Professor of Medicine at the University of Alabama on X, adding:
“Such an elegantly written paragraph in Blood Journal by Luciano J Costa discussing MRD in myeloma (commentary on C. Ola Landgren et al’s work!)
We talk about MRD negativity as a surrogate for OS… in a sense, sCR is a surrogate for MRD negativity!”
Quoting Luciano J Costa‘s post:
“MRD accelerating myeloma drug development – My taken on the landmark EVIDENCE work from C. Ola Landgren and team.”
Read Further.
Source: Rahul Banerjee/X and Luciano J Costa/X